# Naltrexone Implants as Relapse Prevention

> **NCT00269607** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of Oslo** · enrollment: 12 (actual)

## Conditions studied

- Opioid Dependency

## Interventions

- **DRUG:** Implantation of naltrexone implants

## Key facts

- **NCT ID:** NCT00269607
- **Lead sponsor:** University of Oslo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-05
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Recruitment difficulties. Reframed as pilot study
- **Last updated:** 2013-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00269607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00269607, "Naltrexone Implants as Relapse Prevention". Retrieved via AI Analytics 2026-09-12 from https://api.ai-analytics.org/clinical/NCT00269607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*